论文部分内容阅读
目的 研究肝癌合并门静脉癌栓的门静脉金属内支架治疗的临床效果。资料与方法 1 9例肝癌门静脉癌栓患者采用穿肝或穿脾途径置入门静脉金属内支架 ,记录手术成功率 ,狭窄开通率 ,并发症和手术死亡率 ,随访支架通畅期和患者生存期。结果 手术成功率为 94 .7% ,狭窄开通率 77.8% ,2例发生肝性脑病、肝功能衰竭。支架中位通畅期 4个月 ,治疗后 3个月、6个月、1年患者生存率分别为 4 3.8% (7/ 1 6 )、2 5 % (4 / 1 6 )、1 2 .5 % (2 / 1 6 )。结论 巨块型肝癌合并门静脉癌栓 ,无远处广泛转移的患者采用支架置于远端为非肿瘤所在肝叶的治疗方法可取得较好的疗效
Objective To study the clinical effect of portal metal stent treated with portal vein tumor thrombus in patients with hepatocellular carcinoma. Materials and Methods Nineteen patients with hepatocellular carcinoma and portal vein thrombosis were placed into portal metal stent using the method of liver or spleen insertion. The success rate of operation, rate of stenosis, complications and operative mortality were recorded. The follow-up duration of stent and patient’s survival were followed up. Results The successful rate of operation was 94.7%, the rate of stenosis was 77.8%, hepatic encephalopathy and hepatic failure were found in 2 cases. The 4-month median follow-up period was 4 3.8% (7/16), 25% (4/16), and 12.5% respectively at 3 months, 6 months and 1 year after treatment % (2/1 6). Conclusions The treatment of massive liver cancer with portal vein tumor thrombus and extensive metastasis without distant metastasis can be achieved with the treatment of distal non-tumor liver lobe